A detailed history of Schonfeld Strategic Advisors LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 242,476 shares of LRMR stock, worth $921,408. This represents 0.01% of its overall portfolio holdings.

Number of Shares
242,476
Holding current value
$921,408
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.3 - $10.68 $1.53 Million - $2.59 Million
242,476 New
242,476 $1.59 Million
Q1 2024

May 15, 2024

BUY
$4.2 - $13.28 $339,780 - $1.07 Million
80,900 New
80,900 $614,000

Others Institutions Holding LRMR

About Larimar Therapeutics, Inc.


  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $164M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.